| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 1.16e-05 | 270 | 107 | 9 | GO:0050679 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 1.76e-05 | 217 | 107 | 8 | GO:0030856 | |
| GeneOntologyBiologicalProcess | negative regulation of macroautophagy | 3.17e-05 | 35 | 107 | 4 | GO:0016242 | |
| GeneOntologyBiologicalProcess | cellular response to starvation | 5.11e-05 | 185 | 107 | 7 | GO:0009267 | |
| GeneOntologyBiologicalProcess | detection of monosaccharide stimulus | 7.97e-05 | 3 | 107 | 2 | GO:0034287 | |
| GeneOntologyBiologicalProcess | detection of hexose stimulus | 7.97e-05 | 3 | 107 | 2 | GO:0009732 | |
| GeneOntologyBiologicalProcess | detection of carbohydrate stimulus | 7.97e-05 | 3 | 107 | 2 | GO:0009730 | |
| GeneOntologyBiologicalProcess | positive regulation of detection of glucose | 7.97e-05 | 3 | 107 | 2 | GO:2000972 | |
| GeneOntologyBiologicalProcess | regulation of detection of glucose | 7.97e-05 | 3 | 107 | 2 | GO:2000970 | |
| GeneOntologyBiologicalProcess | detection of glucose | 7.97e-05 | 3 | 107 | 2 | GO:0051594 | |
| GeneOntologyBiologicalProcess | positive regulation of keratinocyte proliferation | 1.05e-04 | 18 | 107 | 3 | GO:0010838 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle assembly | 1.53e-04 | 52 | 107 | 4 | GO:1902116 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | IL24 HNF1A LRRK2 DAB1 REG3G ITGA1 STK4 IGF1R RPTOR ETAA1 REG3A GREM1 MMD2 NOTCH2 | 1.80e-04 | 879 | 107 | 14 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | IL24 HNF1A LRRK2 DAB1 REG3G ITGA1 STK4 IGF1R RPTOR ETAA1 REG3A GREM1 MMD2 NOTCH2 | 1.80e-04 | 879 | 107 | 14 | GO:0010562 |
| GeneOntologyBiologicalProcess | response to starvation | 1.93e-04 | 229 | 107 | 7 | GO:0042594 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | IL24 HNF1A LRRK2 DAB1 REG3G STK4 IGF1R RPTOR ETAA1 REG3A GREM1 MMD2 NOTCH2 | 2.00e-04 | 780 | 107 | 13 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 2.04e-04 | 56 | 107 | 4 | GO:0010837 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 2.19e-04 | 57 | 107 | 4 | GO:0061005 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 2.95e-04 | 112 | 107 | 5 | GO:0010507 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 3.43e-04 | 514 | 107 | 10 | GO:0050678 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | IL24 HNF1A LRRK2 DAB1 REG3G ITGA1 STK4 RPTOR ETAA1 TOLLIP REG3A GREM1 MMD2 NOTCH2 | 3.45e-04 | 937 | 107 | 14 | GO:0031401 |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | IL24 HNF1A LRRK2 DAB1 REG3G STK4 RPTOR ETAA1 REG3A GREM1 MMD2 NOTCH2 | 3.75e-04 | 724 | 107 | 12 | GO:0001934 |
| GeneOntologyBiologicalProcess | regulation of kidney size | 3.95e-04 | 6 | 107 | 2 | GO:0035564 | |
| GeneOntologyBiologicalProcess | sexual reproduction | NPHP1 ADAMTS2 LRRK2 FOXA3 DICER1 ITPR1 TDRD7 KMT2C IGF1R EHMT2 NCAPD2 XRN1 KLF17 OSBP2 C2CD6 BOLL CCDC33 | 4.10e-04 | 1312 | 107 | 17 | GO:0019953 |
| GeneOntologyBiologicalProcess | cell morphogenesis | BCL9L LRRK2 DAB1 LAMA2 ITGA1 DICER1 ITPR1 STK4 IGF1R LZTS1 YAP1 NBEAL2 FOXP1 GREM1 RIMS2 NOTCH2 | 4.28e-04 | 1194 | 107 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 4.36e-04 | 262 | 107 | 7 | GO:0031669 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 4.57e-04 | 69 | 107 | 4 | GO:0030857 | |
| GeneOntologyBiologicalProcess | keratinocyte proliferation | 4.82e-04 | 70 | 107 | 4 | GO:0043616 | |
| GeneOntologyBiologicalProcess | lung development | 5.10e-04 | 269 | 107 | 7 | GO:0030324 | |
| Domain | ARM-type_fold | LRRK2 HEATR1 NCAPG2 ELMO1 ITPR1 PIK3R4 THADA RPTOR NBEAL2 NCAPD2 DAAM1 | 3.58e-06 | 339 | 106 | 11 | IPR016024 |
| Domain | HEAT | 7.55e-06 | 48 | 106 | 5 | PF02985 | |
| Domain | HEAT | 1.93e-05 | 58 | 106 | 5 | IPR000357 | |
| Domain | ARM-like | 2.33e-05 | 270 | 106 | 9 | IPR011989 | |
| Domain | - | 3.90e-05 | 222 | 106 | 8 | 1.25.10.10 | |
| Pubmed | BCL9L HNF1A TSHZ3 VEZF1 TNRC6C MRPL2 MFAP1 KMT2C BRD8 ZFHX4 DCP1B EHMT2 YAP1 PRRC2C XRN1 DLAT FOXP1 ZFHX3 YY1AP1 USP54 SRRM2 MNT | 4.46e-10 | 1429 | 108 | 22 | 35140242 | |
| Pubmed | TSHZ3 GGA2 ADAMTS2 POLA1 KIAA0586 LRRK2 LAMA2 HEATR1 ITPR1 IGF1R PRPF40B EHMT2 NCAPD2 SP5 PWWP3B USP54 RIMS2 MNT CCDC33 | 6.33e-09 | 1215 | 108 | 19 | 15146197 | |
| Pubmed | DICER1 MFAP1 THADA BRD8 ZFHX4 PRPF40B EHMT2 RPTOR XRN1 DLAT FOXP1 ZFHX3 IRS2 USP54 KAT6B SRRM2 NOTCH2 SON | 1.04e-08 | 1116 | 108 | 18 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L NELFCD PIK3R4 STK4 IGF1R DCP1B YAP1 PRRC2C RPTOR XRN1 NAV1 IRS2 USP54 SRRM2 NOTCH2 | 7.36e-08 | 861 | 108 | 15 | 36931259 |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 33368532 | ||
| Pubmed | ATMIN ATXN2L VEZF1 HIKESHI POLA1 REG3G KERA HEATR1 FAM186B NCAPG2 DICER1 KMT2C BRD8 EHMT2 XRN1 DLAT DEPDC5 MNT | 1.41e-07 | 1327 | 108 | 18 | 32694731 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN GRID1 TNRC6C CDC42BPB KMT2C THADA IGF1R PER2 RPTOR NBEAL2 NCAPD2 NAV1 DEPDC5 IRS2 MBD5 NOTCH2 | 3.18e-07 | 1105 | 108 | 16 | 35748872 |
| Pubmed | ATXN2L CYP19A1 BRD8 DCP1B EHMT2 YAP1 RPTOR NCAPD2 IRS2 SRRM2 SON | 5.07e-07 | 503 | 108 | 11 | 16964243 | |
| Pubmed | ATXN2L NELFCD HEATR1 ITGA1 NCAPG2 ELMO1 NOMO1 ITPR1 PIK3R4 DCP1B PRRC2C NBEAL2 NCAPD2 XRN1 DAAM1 NOTCH2 | 6.62e-07 | 1168 | 108 | 16 | 19946888 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN NLGN4Y DAB1 TNRC6C CDC42BPB FARP2 PKNOX2 KMT2C THADA IGF1R RPTOR NAV1 FOXP1 ZFHX3 DAAM1 MBD5 KAT6B NOTCH2 | 7.54e-07 | 1489 | 108 | 18 | 28611215 |
| Pubmed | DENND2A GGA2 DICER1 KMT2C RPTOR NBEAL2 NCAPD2 DEPDC5 DAAM1 KAT6B RIMS2 | 8.31e-07 | 529 | 108 | 11 | 14621295 | |
| Pubmed | 1.40e-06 | 255 | 108 | 8 | 15324660 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 31491533 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 36283963 | ||
| Pubmed | Inceptor counteracts insulin signalling in β-cells to control glycaemia. | 3.80e-06 | 34 | 108 | 4 | 33505018 | |
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 5.93e-06 | 82 | 108 | 5 | 31073041 | |
| Pubmed | 6.58e-06 | 418 | 108 | 9 | 34709266 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17998566 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27588468 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19487308 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21187123 | ||
| Pubmed | ORP4L couples IP3 to ITPR1 in control of endoplasmic reticulum calcium release. | 9.55e-06 | 2 | 108 | 2 | 31648575 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26867181 | ||
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 9.55e-06 | 2 | 108 | 2 | 10873665 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7679928 | ||
| Pubmed | YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal. | 9.55e-06 | 2 | 108 | 2 | 32436169 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32560820 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8076648 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32546241 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 34632336 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25938566 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8795446 | ||
| Pubmed | Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. | 9.55e-06 | 2 | 108 | 2 | 21979939 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32352211 | ||
| Pubmed | The interplay between IGF-1R signaling and Hippo-YAP in breast cancer stem cells. | 9.55e-06 | 2 | 108 | 2 | 37081542 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32376130 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33095160 | ||
| Pubmed | miRNAs are required for generating a time delay critical for the circadian oscillator. | 9.55e-06 | 2 | 108 | 2 | 24094851 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10829031 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29544958 | ||
| Pubmed | Regulation of C-type lectin antimicrobial activity by a flexible N-terminal prosegment. | 9.55e-06 | 2 | 108 | 2 | 19095652 | |
| Pubmed | Symbiotic bacteria direct expression of an intestinal bactericidal lectin. | 9.55e-06 | 2 | 108 | 2 | 16931762 | |
| Pubmed | Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. | 9.55e-06 | 2 | 108 | 2 | 24813251 | |
| Pubmed | Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota. | 9.55e-06 | 2 | 108 | 2 | 21694778 | |
| Pubmed | Recombinant Reg3α protein protects against experimental acute pancreatitis in mice. | 9.55e-06 | 2 | 108 | 2 | 26683606 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10564727 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21245462 | ||
| Pubmed | An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice. | 1.29e-05 | 15 | 108 | 3 | 28457749 | |
| Pubmed | BCL9L VEZF1 HEATR1 CDC42BPB DICER1 NOMO1 FARP2 KMT2C BRD8 EHMT2 NCAPD2 XRN1 TOLLIP ZFHX3 DAAM1 SON | 1.55e-05 | 1497 | 108 | 16 | 31527615 | |
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 1.81e-05 | 50 | 108 | 4 | 29560723 | |
| Pubmed | NPHP1 ATXN2L NOMO1 TDRD7 ZC3H10 TOLLIP YY1AP1 USP54 KAT6B CCDC33 | 2.07e-05 | 608 | 108 | 10 | 16713569 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | GGA2 TNRC6C FARP2 PIK3R4 STK4 MFAP1 DCP1B YAP1 RPTOR XRN1 TOLLIP IRS2 CEP97 | 2.08e-05 | 1038 | 108 | 13 | 26673895 |
| Pubmed | 2.29e-05 | 53 | 108 | 4 | 24982181 | ||
| Pubmed | YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration. | 2.30e-05 | 18 | 108 | 3 | 29249464 | |
| Pubmed | Pancreatic STAT3 protects mice against caerulein-induced pancreatitis via PAP1 induction. | 2.86e-05 | 3 | 108 | 2 | 23064197 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 10417963 | ||
| Pubmed | Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations. | 2.86e-05 | 3 | 108 | 2 | 27912059 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 22042863 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 10329612 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 33923774 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 24881775 | ||
| Pubmed | YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression. | 2.86e-05 | 3 | 108 | 2 | 25772357 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 27435623 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19190347 | ||
| Pubmed | The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. | 2.86e-05 | 3 | 108 | 2 | 24324261 | |
| Pubmed | Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart. | 2.86e-05 | 3 | 108 | 2 | 25751817 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 32332916 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21340542 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 14660681 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28099921 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17898946 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30106382 | ||
| Pubmed | THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer. | 2.86e-05 | 3 | 108 | 2 | 28193878 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 31990985 | ||
| Pubmed | Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. | 2.86e-05 | 3 | 108 | 2 | 31145701 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21628386 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 24810113 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 34099862 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 27143303 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L MFAP1 BRD8 YAP1 RPTOR YY1AP1 IRS2 KAT6B SRRM2 NOTCH2 SON | 3.01e-05 | 774 | 108 | 11 | 15302935 |
| Pubmed | 3.19e-05 | 20 | 108 | 3 | 20075150 | ||
| Pubmed | 3.19e-05 | 20 | 108 | 3 | 35177643 | ||
| Pubmed | ATXN2L POLA1 HEATR1 DICER1 PRRC2C NCAPD2 XRN1 DLAT SRRM2 SON | 3.78e-05 | 653 | 108 | 10 | 22586326 | |
| Pubmed | 4.17e-05 | 407 | 108 | 8 | 12693553 | ||
| Pubmed | 4.30e-05 | 22 | 108 | 3 | 19794065 | ||
| Pubmed | 4.30e-05 | 22 | 108 | 3 | 11696558 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 4.65e-05 | 536 | 108 | 9 | 15840001 | |
| Pubmed | 4.78e-05 | 538 | 108 | 9 | 10512203 | ||
| Pubmed | 4.93e-05 | 23 | 108 | 3 | 28190640 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 5.56e-05 | 424 | 108 | 8 | 21731673 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 30673917 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 23147030 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 22727489 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20947509 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20600896 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 19343564 | ||
| Pubmed | Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization. | 5.71e-05 | 4 | 108 | 2 | 23867474 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 22723890 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 36240758 | ||
| Pubmed | YAP regulates alveolar epithelial cell differentiation and AGER via NFIB/KLF5/NKX2-1. | 5.71e-05 | 4 | 108 | 2 | 34466790 | |
| Interaction | YWHAG interactions | ATXN2L HNF1A NELFCD LRRK2 FARP2 PIK3R4 STK4 MFAP1 IGF1R DCP1B YAP1 PRRC2C RPTOR NAV1 IRS2 USP54 SRRM2 CEP97 NOTCH2 SON | 5.96e-06 | 1248 | 105 | 20 | int:YWHAG |
| Interaction | FOXI1 interactions | 8.59e-06 | 92 | 105 | 6 | int:FOXI1 | |
| Interaction | FOXL1 interactions | 8.64e-06 | 196 | 105 | 8 | int:FOXL1 | |
| Interaction | FEV interactions | 1.12e-05 | 203 | 105 | 8 | int:FEV | |
| Interaction | CPEB4 interactions | 1.76e-05 | 156 | 105 | 7 | int:CPEB4 | |
| Interaction | VSX1 interactions | 2.42e-05 | 66 | 105 | 5 | int:VSX1 | |
| Interaction | ZBTB39 interactions | 2.53e-05 | 33 | 105 | 4 | int:ZBTB39 | |
| Interaction | TEAD1 interactions | 3.81e-05 | 176 | 105 | 7 | int:TEAD1 | |
| Interaction | LHX2 interactions | 4.88e-05 | 183 | 105 | 7 | int:LHX2 | |
| Interaction | YWHAH interactions | ATXN2L NELFCD LRRK2 PIK3R4 STK4 DCP1B YAP1 PRRC2C RPTOR XRN1 NAV1 IRS2 GREM1 USP54 RIMS2 SRRM2 NOTCH2 | 5.30e-05 | 1102 | 105 | 17 | int:YWHAH |
| Interaction | PAX9 interactions | 6.13e-05 | 130 | 105 | 6 | int:PAX9 | |
| Interaction | HNF1B interactions | 6.19e-05 | 190 | 105 | 7 | int:HNF1B | |
| Interaction | TRIM52 interactions | 6.95e-05 | 133 | 105 | 6 | int:TRIM52 | |
| Interaction | GSC interactions | 9.18e-05 | 87 | 105 | 5 | int:GSC | |
| Interaction | LATS1 interactions | 1.01e-04 | 440 | 105 | 10 | int:LATS1 | |
| Interaction | DPRX interactions | 1.06e-04 | 18 | 105 | 3 | int:DPRX | |
| Interaction | H2BC9 interactions | ADAMTS2 LAMA2 CDC42BPB ADGRG4 MRPL2 ZFHX4 DLAT DEPDC5 MBD5 KAT6B | 1.13e-04 | 446 | 105 | 10 | int:H2BC9 |
| Interaction | SOX2 interactions | ATXN2L BCL9L TSHZ3 MAB21L4 HEATR1 MRPL2 MFAP1 KMT2C BRD8 ZFHX4 EHMT2 LZTS1 YAP1 NCAPD2 XRN1 TOLLIP FOXP1 ZFHX3 KAT6B | 1.26e-04 | 1422 | 105 | 19 | int:SOX2 |
| Interaction | TLE3 interactions | 1.55e-04 | 376 | 105 | 9 | int:TLE3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.66e-05 | 15 | 72 | 3 | 529 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TSHZ3 GGA2 SHISA2 ITGA1 NCAPG2 DICER1 ELMO1 ITPR1 PKNOX2 BRD8 LZTS1 XRN1 ETAA1 NAV1 FOXP1 DAAM1 CEP97 NOTCH2 | 1.17e-07 | 1009 | 106 | 18 | M157 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 5.18e-06 | 166 | 106 | 7 | M6826 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 | 9.00e-06 | 69 | 106 | 5 | M1145 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 | 1.36e-05 | 75 | 106 | 5 | MM868 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP | 1.69e-05 | 199 | 106 | 7 | M9366 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | VEZF1 DICER1 ITPR1 TDRD7 PIK3R4 IGF1R YAP1 PRRC2C ZFHX3 DAAM1 KAT6B MNT SON | 4.25e-05 | 856 | 106 | 13 | M4500 |
| Coexpression | GSE14415_INDUCED_TREG_VS_TCONV_DN | 5.76e-05 | 165 | 106 | 6 | M2960 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.13e-06 | 195 | 106 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | ATXN2L TSHZ3 ADAMTS2 SHISA2 TNRC6C BRD8 ZFHX4 TRIM17 NCAPD2 DLAT FOXP1 ZFHX3 PWWP3B KAT6B | 3.90e-05 | 791 | 106 | 14 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-09 | 156 | 108 | 8 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.42e-08 | 193 | 108 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.52e-08 | 194 | 108 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-08 | 195 | 108 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-07 | 157 | 108 | 7 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.24e-07 | 183 | 108 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-07 | 184 | 108 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.61e-07 | 186 | 108 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-07 | 191 | 108 | 7 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-07 | 127 | 108 | 6 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 145 | 108 | 6 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 150 | 108 | 6 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-06 | 150 | 108 | 6 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 3.83e-06 | 171 | 108 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.96e-06 | 172 | 108 | 6 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.67e-06 | 177 | 108 | 6 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.21e-06 | 186 | 108 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.40e-06 | 187 | 108 | 6 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.40e-06 | 187 | 108 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.60e-06 | 188 | 108 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 6.81e-06 | 189 | 108 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.67e-06 | 193 | 108 | 6 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.14e-06 | 195 | 108 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-06 | 196 | 108 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-06 | 196 | 108 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-06 | 196 | 108 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.38e-06 | 196 | 108 | 6 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-06 | 198 | 108 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.87e-06 | 198 | 108 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.13e-06 | 199 | 108 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-05 | 169 | 108 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-05 | 174 | 108 | 5 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-05 | 174 | 108 | 5 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.96e-05 | 176 | 108 | 5 | 71f96cace3f20fbef975037f4deff9b82b0282a1 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 177 | 108 | 5 | 7ac99ff16df94b4e08d361e3d98a7b3af8d6ee3b | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 177 | 108 | 5 | 092a345cb802f183322aa5542341ba2d96d4f06a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.35e-05 | 178 | 108 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 7.74e-05 | 180 | 108 | 5 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.37e-05 | 183 | 108 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 184 | 108 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-05 | 184 | 108 | 5 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.59e-05 | 184 | 108 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-05 | 184 | 108 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 8.81e-05 | 185 | 108 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 185 | 108 | 5 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 187 | 108 | 5 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 187 | 108 | 5 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 187 | 108 | 5 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.27e-05 | 187 | 108 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.50e-05 | 188 | 108 | 5 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.99e-05 | 190 | 108 | 5 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 9.99e-05 | 190 | 108 | 5 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.99e-05 | 190 | 108 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.99e-05 | 190 | 108 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.99e-05 | 190 | 108 | 5 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 9.99e-05 | 190 | 108 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.99e-05 | 190 | 108 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-04 | 191 | 108 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 191 | 108 | 5 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-04 | 191 | 108 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 191 | 108 | 5 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-04 | 191 | 108 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 192 | 108 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 192 | 108 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 192 | 108 | 5 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| Disease | free androgen index | 5.92e-05 | 374 | 105 | 8 | EFO_0007005 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.10e-04 | 69 | 105 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 1.23e-04 | 215 | 105 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | acute pancreatitis (implicated_via_orthology) | 1.25e-04 | 5 | 105 | 2 | DOID:2913 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.74e-04 | 145 | 105 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 3.09e-04 | 255 | 105 | 6 | EFO_0009924 | |
| Disease | Neurodevelopmental Disorders | 3.47e-04 | 93 | 105 | 4 | C1535926 | |
| Disease | diet measurement | SLC4A8 ACSS1 LAMA2 GRID1 FAM186B ITPR1 THADA PRPF40B FOXP1 ZFHX3 DEPDC5 MBD5 | 3.58e-04 | 1049 | 105 | 12 | EFO_0008111 |
| Disease | Prostatic Neoplasms | 3.61e-04 | 616 | 105 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.61e-04 | 616 | 105 | 9 | C0376358 | |
| Disease | serum gamma-glutamyl transferase measurement | HNF1A SLC4A8 ITGA1 CDC42BPB ITPR1 FARP2 THADA IGF1R NBEAL2 YY1AP1 NOTCH2 | 4.18e-04 | 914 | 105 | 11 | EFO_0004532 |
| Disease | formal thought disorder | 5.54e-04 | 10 | 105 | 2 | EFO_0004805 | |
| Disease | pneumonia (implicated_via_orthology) | 5.54e-04 | 10 | 105 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 5.57e-04 | 45 | 105 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 5.57e-04 | 45 | 105 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | testosterone measurement | ATXN2L HNF1A CYP19A1 FOXA3 FARP2 PKNOX2 THADA LIPE ZFHX4 YAP1 FOXP1 ZFHX3 YY1AP1 | 6.00e-04 | 1275 | 105 | 13 | EFO_0004908 |
| Disease | central corneal thickness, intraocular pressure measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0004695, EFO_0005213 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 8.09e-04 | 12 | 105 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | age of onset of multiple sclerosis | 8.09e-04 | 12 | 105 | 2 | OBA_2001029 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.06e-03 | 56 | 105 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Adenocarcinoma Of Esophagus | 1.11e-03 | 14 | 105 | 2 | C0279628 | |
| Disease | sulfate measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0007864 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 1.19e-03 | 221 | 105 | 5 | C0011860 | |
| Disease | quinate measurement | 1.28e-03 | 15 | 105 | 2 | EFO_0021167 | |
| Disease | pulse pressure measurement | ITGA1 FAM186B PIK3R4 ZFHX4 PRPF40B YAP1 RPTOR NAV1 REG3A FOXP1 ZFHX3 MBD5 CEP97 | 1.34e-03 | 1392 | 105 | 13 | EFO_0005763 |
| Disease | Malignant neoplasm of breast | IL24 CYP19A1 LAMA2 PIK3R4 LIPE IGF1R PER2 YAP1 USP54 KAT6B NOTCH2 | 1.55e-03 | 1074 | 105 | 11 | C0006142 |
| Disease | alcohol consumption measurement | ATXN2L HNF1A SLC4A8 ACSS1 GRID1 MFAP1 RPTOR XRN1 FOXP1 ZFHX3 RIMS2 CCDC33 | 1.55e-03 | 1242 | 105 | 12 | EFO_0007878 |
| Disease | sphingomyelin 14:0 measurement | 1.65e-03 | 17 | 105 | 2 | EFO_0010390 | |
| Disease | urate measurement, bone density | 1.68e-03 | 619 | 105 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Parkinson's disease (is_marker_for) | 1.78e-03 | 67 | 105 | 3 | DOID:14330 (is_marker_for) | |
| Disease | sphingosine 1-phosphate measurement | 1.85e-03 | 18 | 105 | 2 | EFO_0800185 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 1.85e-03 | 18 | 105 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | response to ketamine | 1.93e-03 | 69 | 105 | 3 | EFO_0009748 | |
| Disease | attention function measurement | 1.96e-03 | 148 | 105 | 4 | EFO_0007636 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 2.06e-03 | 19 | 105 | 2 | OBA_2045199 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.26e-03 | 801 | 105 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | colorectal cancer (is_marker_for) | 2.43e-03 | 157 | 105 | 4 | DOID:9256 (is_marker_for) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 2.52e-03 | 21 | 105 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Endometrioma | 2.66e-03 | 161 | 105 | 4 | C0269102 | |
| Disease | Endometriosis | 2.66e-03 | 161 | 105 | 4 | C0014175 | |
| Disease | circadian rhythm | 2.78e-03 | 163 | 105 | 4 | EFO_0004354 | |
| Disease | alcohol drinking | 3.05e-03 | 81 | 105 | 3 | EFO_0004329 | |
| Disease | sphingomyelin measurement | 3.21e-03 | 278 | 105 | 5 | EFO_0010118 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 3.29e-03 | 24 | 105 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | Parkinson Disease | 3.50e-03 | 85 | 105 | 3 | C0030567 | |
| Disease | cleft lip | 3.52e-03 | 284 | 105 | 5 | EFO_0003959 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PAMAMRPFFGIVPVL | 466 | Q9NUB1 | |
| NPAMDFTQTPPGMLA | 366 | Q92556 | |
| ITPLSFPIPSMMNFD | 431 | Q8N5R6 | |
| FPIPSMMNFDVPRVS | 436 | Q8N5R6 | |
| QATIVMMPALPAPSS | 306 | Q9H0E9 | |
| VPNVPTMLPRESSMA | 1491 | Q8IZF6 | |
| QVYAPSAITMPAPVM | 256 | Q8N9W6 | |
| PPSVQSLAMRLLSMP | 141 | Q96KQ7 | |
| QLFSPLPPSPMAMIR | 366 | Q8IYM0 | |
| PMMRPLIEKFSANVP | 1836 | Q9UPY3 | |
| IDVFMPTLPVPTVAM | 1116 | O95450 | |
| QPVFAPMLQSNPRML | 811 | Q8WWM7 | |
| MAANFTPPMQLAEIP | 1771 | Q8WYB5 | |
| ALINPFAPSRMPMKL | 596 | O75140 | |
| MPAPALPTSAMAVQV | 1 | Q08AI8 | |
| ARLPSVAFPTAMMPQ | 2346 | Q04721 | |
| VMGFFPALVILSMPN | 191 | Q8IY49 | |
| MSVPSALMKQPPIQS | 1 | P55081 | |
| SSMTRPVLMPNQDPF | 2236 | Q8NEZ4 | |
| STPPKLMPFSNQLEM | 101 | Q9Y250 | |
| TVLFKMFTSMDPPPV | 311 | Q8IXH7 | |
| TMMVTLNCPELQPPT | 151 | O60565 | |
| FLPMTPMAAAPEGNV | 951 | Q14643 | |
| QKITEPSMFMNLAPP | 256 | Q53TS8 | |
| NPVLAPPSLSKMIQM | 1101 | P08069 | |
| FPAPLAPVMAFMLPS | 896 | O15055 | |
| ADMFLLVPPLMNPIV | 276 | Q8NH64 | |
| PPHMQVLLPALSPTM | 216 | P10515 | |
| MALPITNGTLFMPFV | 1 | A6NMU1 | |
| PALQVPVSVAMMTPQ | 91 | Q9H334 | |
| LSLPSSLPQMPMTQT | 261 | Q86SU0 | |
| PQTFPLTVTNRPMMD | 481 | Q15155 | |
| RMNFLAAMPFLPPSM | 1161 | Q5S007 | |
| AAMPFLPPSMTILKL | 1166 | Q5S007 | |
| TVLNPVTMVTMPSFP | 561 | Q99583 | |
| LMPPVQSHVTQSPFM | 476 | P20823 | |
| AFSPLMPPAVISQML | 556 | Q9UJY4 | |
| QMVMSINLTGPLPAP | 1591 | P24043 | |
| MQVLMDLPLSAVPPS | 1601 | Q9Y5S2 | |
| PMPELKLSISFPNMT | 996 | P56199 | |
| SRIPMPVNFNEPLSM | 536 | Q969R2 | |
| DVSPPPLVVMAFSMK | 531 | P09884 | |
| PFAMQNIDMPELFPS | 391 | Q9NY74 | |
| MPSVFSPDNPLMLSA | 51 | Q86Y26 | |
| SPMSPGMLRDVPQFL | 791 | Q9UQ26 | |
| MPMSPASVSAPKQIL | 676 | Q9Y4H2 | |
| IPFMTPNTITMIPNT | 771 | Q8NFZ3 | |
| PATAAPSLLMSPMVF | 516 | Q8IZD4 | |
| PSLLMSPMVFAQPTS | 521 | Q8IZD4 | |
| FALQTMEPALPMPPV | 36 | Q9Y4D1 | |
| LPVMQFSVMPVFVPT | 306 | O43313 | |
| AQMTPSPSEMFIPAN | 161 | Q53FT3 | |
| PAAFMPTQTVMPLPA | 396 | O75553 | |
| PTQTVMPLPAAMFQG | 401 | O75553 | |
| IVPEAMPAATMPVLL | 16 | P11511 | |
| QPLMRSVMEAPFPAL | 696 | Q9ULE3 | |
| IPKMVPAEMSSPALA | 491 | A2CJ06 | |
| SIMNNPCVMATPSIP | 201 | Q8IW35 | |
| PFCPPLLATASQMQM | 16 | Q13007 | |
| DPTPSQNPLSLMMTQ | 1076 | Q86UU0 | |
| APVRPVTLNMNVAMP | 56 | O75608 | |
| NTMFPPTANMLLPTG | 621 | Q9P267 | |
| LPLPLSSSATMPSMQ | 951 | Q9ULK0 | |
| AQAVLPSMAQMLPPQ | 201 | Q5JT82 | |
| PQLPSLMPSLLTTMK | 1731 | Q9H583 | |
| MPATLMTLLFSNIDP | 571 | O94887 | |
| SVTALLPSLMLPMFG | 56 | Q9BZW2 | |
| VMPFANLMSLLGPSI | 291 | Q9NVU0 | |
| SPAPALTMMATQNVP | 6 | Q96KN3 | |
| SHPMLATFPMLLEQP | 606 | O15259 | |
| KNPFMSPLLAPDSML | 966 | Q05469 | |
| MLPPMALPSVSWMLL | 1 | Q6UW15 | |
| ESLQMPMSLPSAFPS | 886 | Q8NEY1 | |
| MLPPMALPSVSWMLL | 1 | Q06141 | |
| MLCQLLPMQPVPESS | 1066 | Q6YHU6 | |
| PALLTSPINPQHMTM | 1136 | Q9HCJ0 | |
| SPVKMLPSSMAALPA | 126 | Q6BEB4 | |
| ARMSQVPAPVPLMSL | 2206 | Q9UQ35 | |
| FAPPLSPLSSDMLIM | 236 | Q5H9M0 | |
| VPTMAPLNSYMTLNP | 31 | P55318 | |
| FDLTPSMAGIMVPPV | 581 | Q6ZNJ1 | |
| NMPPRLPANTMQLFL | 206 | O60938 | |
| ALASQMPPPLTTGLM | 2761 | Q9Y520 | |
| SVPMTAVPPFMDGLQ | 256 | Q6UWI4 | |
| ASPAAIVFPMMVLAL | 971 | Q2Y0W8 | |
| NTFMEDITVPPLMIP | 446 | Q8NHU6 | |
| MPLPPSMKNCIQLAA | 231 | Q8N122 | |
| GPPLLLPSMLMFAVI | 36 | Q8NCH0 | |
| PKESPAMLPTFLLMN | 911 | Q15021 | |
| LFMLMSFMPASAVPP | 671 | Q86XI2 | |
| MEPSKTFMRNLPITP | 1 | Q8WW14 | |
| SMFGSLDPPNMPQAL | 861 | Q99570 | |
| VSLDLPLFPSIMMQP | 2026 | Q86UP3 | |
| MNLPTPMTLAAPLNI | 486 | Q14119 | |
| PMTLAAPLNIAMRPV | 491 | Q14119 | |
| APLNIAMRPVESMPF | 496 | Q14119 | |
| AMRPVESMPFLPQAL | 501 | Q14119 | |
| SYALLPAAMVMPPQP | 171 | Q9H0E2 | |
| MLSQMNVTAPTSPPV | 206 | P46937 | |
| PQPDFSFLRMPQTMT | 1456 | Q8IZH2 | |
| AAPAPSLFPAAQMMN | 21 | Q5T653 | |
| MLMPAVPVTAATAPG | 66 | Q6NWY9 | |
| AAKPSLPALDPMSML | 736 | Q63HK5 | |
| APFTSIPSMMTQPLL | 216 | O15060 | |
| STFSALTPVMLMEPP | 401 | Q9Y577 | |
| QTLLSSAPVPKVMMP | 546 | Q9H869 | |
| TPMALQVQLAMSPSP | 416 | Q96NM4 | |
| DIHPMRAIFMIPTNP | 226 | Q13043 | |
| QTIAQGMAPPPVSMA | 371 | Q96K80 | |
| QAPMSSAMLLVAVPF | 191 | Q7Z769 | |
| PPAMAAPESSAMAVL | 1346 | P18583 | |
| PPAKMSVMLPSVNLE | 1496 | Q9BVV6 | |
| TQLSMPMELPIFSPL | 2086 | Q15911 | |
| PQPQFLSPDVLMPTM | 1476 | Q70EL1 | |
| VSQPSMNTKPFMPIA | 721 | Q14324 |